AstraZeneca, Cancer Research UK, Institute of Cancer Research deal

AstraZeneca licensed from Cancer Research UK exclusive, worldwide rights to a portfolio of undisclosed compounds targeting molecular chaperones to treat cancer discovered by the institute. The compoun...